Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Vitamin C [EPC]
Sus Scrofa Lung is a biological active ingredient derived from porcine lung tissue, categorized within the Vitamin C and Allergenic Extract pharmacologic classes. It is primarily utilized in specialized therapeutic formulations and glandular therapy to support respiratory and immune function.
Name
Sus Scrofa Lung
Raw Name
SUS SCROFA LUNG
Category
Vitamin C [EPC]
Drug Count
27
Variant Count
32
Last Verified
February 17, 2026
About Sus Scrofa Lung
Sus Scrofa Lung is a biological active ingredient derived from porcine lung tissue, categorized within the Vitamin C and Allergenic Extract pharmacologic classes. It is primarily utilized in specialized therapeutic formulations and glandular therapy to support respiratory and immune function.
Detailed information about Sus Scrofa Lung
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Lung.
Sus Scrofa Lung refers to the processed biological tissue derived from the lungs of the domestic pig (Sus scrofa). In the context of modern pharmacology and clinical medicine, this ingredient is classified under several Established Pharmacologic Classes (EPC), most notably Vitamin C [EPC] and Non-Standardized Plant/Food/Insect Allergenic Extract [EPC]. While the raw material is biological in origin, its clinical application spans from nutritional supplementation to complex immunotherapy. Sus Scrofa Lung belongs to a class of drugs called biological extracts or glandulars, which are substances derived from animal organs to provide specific proteins, enzymes, and co-factors that may be deficient in a patient or required for a specific therapeutic response.
Historically, the use of porcine-derived tissues has been a cornerstone of endocrinology and pulmonology. For instance, porcine lung is the primary source for pulmonary surfactants (such as poractant alfa), which have revolutionized the treatment of Respiratory Distress Syndrome (RDS) in neonates. According to FDA-approved labeling for various biological products, porcine-derived materials must undergo rigorous purification to ensure the absence of zoonotic pathogens. In the specific context of the Vitamin C [EPC] classification, Sus Scrofa Lung is often utilized in formulations where the natural co-factors found in lung tissue—such as ascorbic acid and specific peptides—are thought to enhance the bioavailability or therapeutic efficacy of the primary active ingredient.
The mechanism of action for Sus Scrofa Lung is multifaceted and depends heavily on its clinical application. At the molecular level, when used as a source of Vitamin C, it provides l-ascorbic acid, a crucial electron donor for various enzymes. This includes those involved in collagen synthesis, carnitine biosynthesis, and the regulation of gene expression via hypoxia-inducible factors. Within the lung tissue matrix, these biochemical processes are essential for maintaining the structural integrity of the alveolar basement membrane.
When utilized as an Allergenic Extract [EPC], Sus Scrofa Lung works through the modulation of the immune system. It interacts with dendritic cells and T-lymphocytes to induce immunological tolerance. By exposing the patient to controlled, minute amounts of porcine-derived proteins, the immune system may shift from a Th2-dominated allergic response to a Th1-mediated or T-regulatory (Treg) response. This reduces the production of IgE antibodies and decreases the degranulation of mast cells and basophils upon subsequent exposure to similar biological proteins. Furthermore, the presence of porcine surfactants within the extract can lower surface tension at the air-liquid interface of the alveoli, theoretically supporting respiratory mechanics in specific clinical contexts.
Understanding the pharmacokinetics of a complex biological extract like Sus Scrofa Lung requires looking at its primary constituents:
Sus Scrofa Lung is utilized in several clinical scenarios, often as part of a multi-ingredient formulation:
Sus Scrofa Lung is available in several specialized dosage forms to accommodate different therapeutic needs:
> Important: Only your healthcare provider can determine if Sus Scrofa Lung is right for your specific condition. The use of animal-derived biologicals requires a careful assessment of the patient's medical history and potential for allergic cross-reactivity.
The dosage of Sus Scrofa Lung is not standardized across all products because it is often part of a complex biological matrix. However, general guidelines based on clinical practice include:
Sus Scrofa Lung must be used with extreme caution in pediatric populations.
Patients with significant renal impairment (e.g., GFR < 30 mL/min) should use Sus Scrofa Lung with caution. The Vitamin C component can lead to increased urinary oxalate levels, potentially increasing the risk of calcium oxalate kidney stones. Dose reductions or increased hydration may be necessary.
While the liver is the primary site for the metabolism of amino acids derived from the extract, standard hepatic impairment does not usually require specific dose adjustments unless the patient has end-stage liver disease or hepatic encephalopathy, where protein intake must be strictly monitored.
Geriatric patients often have reduced gastric acid production (achlorhydria), which may impair the digestion and absorption of the biological proteins in Sus Scrofa Lung. Healthcare providers may recommend taking the supplement with a slightly acidic beverage or adjusting the dose to ensure efficacy while monitoring for gastrointestinal distress.
If you miss a dose of Sus Scrofa Lung, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of an adverse allergic reaction or gastrointestinal upset.
Signs of an acute overdose of Sus Scrofa Lung may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on maintaining airway patency and managing gastrointestinal symptoms.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance, as biological extracts can have cumulative effects on the immune system.
Most patients tolerate Sus Scrofa Lung well, but common reactions can occur, particularly when beginning therapy. These include:
> Warning: Stop taking Sus Scrofa Lung and call your doctor immediately if you experience any of these symptoms, as they may indicate a severe hypersensitivity reaction:
With prolonged use of Sus Scrofa Lung, the primary concern is the development of immunological sensitization. Over months or years, the body may develop antibodies against porcine proteins, which could lead to a loss of efficacy or an increased risk of allergic reactions to other porcine-derived products (such as certain types of insulin or heparin). Additionally, long-term high-dose Vitamin C intake from the extract can lead to the formation of kidney stones in susceptible individuals. Regular monitoring of renal function and immune markers is recommended for patients on long-term therapy.
Currently, there are no FDA black box warnings specifically for Sus Scrofa Lung as a standalone ingredient. However, porcine-derived products used in clinical settings (like surfactants) carry warnings regarding the risk of rapid changes in lung compliance and the potential for oxygen toxicity if not monitored by a specialist. Always consult the specific labeling of the brand-name product you are using.
Report any unusual symptoms to your healthcare provider. Even mild symptoms can be early indicators of a developing sensitivity to the biological components of the extract.
Sus Scrofa Lung is a biological product derived from animal tissue. Patients must be aware that while modern manufacturing processes involve rigorous screening for pathogens, the risk of transmission of known or unknown infectious agents (zoonoses) cannot be entirely eliminated. Furthermore, because this product is classified under the Allergenic Extract [EPC], it has the potential to cause significant immune system modulation. Patients with a history of asthma or severe allergies must be monitored closely during the initiation of therapy.
No FDA black box warnings for Sus Scrofa Lung. However, caution is advised when using porcine-derived extracts in patients with known hypersensitivity to pork products.
To ensure the safe use of Sus Scrofa Lung, healthcare providers typically require the following monitoring:
Sus Scrofa Lung generally does not cause drowsiness or cognitive impairment. However, if a patient experiences a mild allergic reaction (such as dizziness or itching), they should refrain from driving or operating heavy machinery until the symptoms have completely resolved.
There is no direct pharmacological interaction between Sus Scrofa Lung and alcohol. However, alcohol can increase the permeability of the gut lining (leaky gut), which may lead to an increased and unpredictable absorption of porcine proteins, potentially raising the risk of an allergic reaction. Moderate to heavy alcohol consumption should be avoided while taking this medication.
For most patients, Sus Scrofa Lung can be discontinued without a tapering schedule. However, if the patient has been using the extract as part of an immunotherapy protocol, stopping suddenly may lead to a return of allergic symptoms. Always consult your healthcare provider before stopping the medication to ensure that your underlying condition remains managed.
> Important: Discuss all your medical conditions, including any history of asthma, kidney stones, or food allergies, with your healthcare provider before starting Sus Scrofa Lung.
Sus Scrofa Lung can affect several laboratory results:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including any 'natural' or 'organic' porcine products, to avoid potentially dangerous interactions.
Sus Scrofa Lung must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to other mammalian meats (such as beef or lamb) may experience cross-reactivity with Sus Scrofa Lung, a phenomenon sometimes associated with the 'alpha-gal' carbohydrate found in mammalian tissues. Additionally, those with sensitivities to certain insect or plant allergens (as noted in the EPC classes) should be monitored for unexpected cross-allergic responses.
> Important: Your healthcare provider will evaluate your complete medical history, including dietary restrictions and allergy profiles, before prescribing Sus Scrofa Lung.
Sus Scrofa Lung is categorized as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans. There is a theoretical risk that porcine proteins could cross the placental barrier and sensitize the fetal immune system. Therefore, Sus Scrofa Lung should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is particularly important to avoid initiation of allergenic extract therapy during the first trimester.
It is unknown whether the specific biological components of Sus Scrofa Lung are excreted in human milk. While Vitamin C is a normal constituent of breast milk, foreign porcine proteins could potentially pass to the infant and cause sensitization or allergic reactions. Nursing mothers should consult their pediatrician before using this product. If the infant develops a rash, diarrhea, or respiratory congestion, breastfeeding should be paused and medical advice sought.
The safety and effectiveness of Sus Scrofa Lung in pediatric patients have not been established through large-scale clinical trials. While porcine-derived surfactants are used in neonates, the use of oral or injectable lung extracts in children is generally avoided due to the high risk of developing lifelong allergies to animal proteins. If used, dosing must be strictly weight-based and supervised by a pediatric specialist.
Clinical studies of Sus Scrofa Lung did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. There is an increased risk of Vitamin C-induced kidney stones in the elderly due to age-related declines in GFR (Glomerular Filtration Rate).
In patients with renal impairment, the clearance of oxalate (a metabolite of the Vitamin C component) is reduced. This can lead to systemic oxalosis or the formation of renal calculi. For patients with a GFR between 30-60 mL/min, a 50% dose reduction is often recommended. For those with a GFR < 30 mL/min, use is generally discouraged unless the clinical need is critical.
No specific dose adjustments are typically required for mild to moderate hepatic impairment. However, in patients with severe cirrhosis, the liver's ability to process the nitrogenous waste from the protein components of the extract may be compromised. These patients should be monitored for signs of hyperammonemia.
> Important: Special populations require individualized medical assessment to balance the unique biological risks of animal-derived extracts with therapeutic goals.
Sus Scrofa Lung operates through several distinct pharmacological pathways. As a Vitamin C [EPC], it provides ascorbic acid which acts as a potent antioxidant and a cofactor for protocollagen hydroxylase, an enzyme essential for the formation of mature collagen fibers. This is particularly relevant in the lung parenchyma, where collagen provides the structural framework for gas exchange.
In its role as an Allergenic Extract [EPC], the mechanism involves 'immunological desensitization.' The porcine proteins act as antigens that are processed by antigen-presenting cells (APCs). When administered in controlled, escalating doses, these antigens promote the development of IgG4 'blocking antibodies.' These antibodies compete with IgE for binding sites on the allergen, thereby preventing the allergic cascade. Furthermore, porcine lung tissue contains natural pulmonary surfactants (phospholipids and proteins like SP-B and SP-C) that can theoretically assist in maintaining alveolar stability by reducing surface tension.
The dose-response relationship for Sus Scrofa Lung is non-linear, especially in its allergenic applications. The onset of the antioxidant effect from Vitamin C is rapid (within hours), while the immunological effects of the extract may take weeks or months to become clinically evident. Tolerance to the porcine proteins typically develops over a period of 6 to 12 months of consistent exposure. There is no evidence of traditional pharmacological 'tolerance' (tachyphylaxis) to the Vitamin C component, although the body's absorption efficiency decreases as intake increases.
| Parameter | Value |
|---|---|
| Bioavailability | 70-90% (for Vitamin C component at low doses) |
| Protein Binding | 25% (Ascorbic acid); Variable for porcine peptides |
| Half-life | 10–20 days (Vitamin C); 2-4 hours (Peptides) |
| Tmax | 2–3 hours (Oral) |
| Metabolism | Hepatic (Proteolysis and Oxidation) |
| Excretion | Renal (Mainly as oxalate and amino acid metabolites) |
Sus Scrofa Lung is classified as a Biological Extract and a Nutritional/Allergenic Agent. It shares therapeutic space with other animal-derived extracts (like bovine lung) and synthetic Vitamin C supplements. Within the EPC system, it is uniquely positioned across Vitamin C and multiple Allergenic Extract categories, reflecting its diverse biological utility.
Common questions about Sus Scrofa Lung
Sus Scrofa Lung is primarily used as a biological source of organ-specific nutrients and Vitamin C to support respiratory and immune health. In clinical settings, it may also be used as an allergenic extract for the diagnosis or treatment of specific sensitivities to porcine proteins. Some healthcare providers prescribe it as part of 'glandular therapy' to provide the body with peptides and co-factors found naturally in lung tissue. Additionally, it serves as the raw material for producing life-saving surfactants used in neonatal intensive care. Always consult your doctor to understand the specific reason they have recommended this extract for you.
The most common side effects associated with Sus Scrofa Lung include mild gastrointestinal issues such as bloating, gas, and abdominal discomfort. Some patients also report a transient metallic or meaty aftertaste after taking oral capsules. Mild skin itching or a faint rash can occur in individuals with a slight sensitivity to porcine proteins. These symptoms are usually temporary and often resolve as the body adjusts to the supplement. However, if these symptoms persist or worsen, it is important to contact your healthcare provider for a dosage adjustment.
It is generally recommended to avoid or significantly limit alcohol consumption while taking Sus Scrofa Lung. Alcohol can increase the permeability of the intestinal lining, which may lead to an unpredictable and rapid absorption of the porcine proteins in the extract. This increased absorption can raise the risk of a systemic allergic reaction or sensitivity. Furthermore, alcohol can deplete the body's stores of Vitamin C, potentially counteracting the nutritional benefits of the supplement. Discuss your alcohol intake with your doctor to ensure the safe use of this biological product.
The safety of Sus Scrofa Lung during pregnancy has not been definitively established, and it is classified as FDA Pregnancy Category C. There are no adequate human studies to determine if porcine-derived proteins can affect fetal development or cause sensitization in the womb. Because of the potential for severe allergic reactions (anaphylaxis) which could deprive the fetus of oxygen, use is generally restricted to situations where it is medically essential. If you are pregnant or planning to become pregnant, you must discuss the risks and benefits with your obstetrician. Initiation of new allergenic extracts is typically avoided during pregnancy.
The time it takes for Sus Scrofa Lung to work depends on the condition being treated. For nutritional support and antioxidant benefits from the Vitamin C component, effects may begin within a few days. However, when used as an allergenic extract or for glandular support of the respiratory system, it can take 4 to 12 weeks of consistent use to notice a clinical difference. Immunological changes, such as desensitization, typically require 6 to 12 months of therapy to reach full effect. Patience and consistent dosing are key to achieving the desired therapeutic outcomes.
In most cases, Sus Scrofa Lung can be stopped suddenly without causing withdrawal symptoms. However, if you are using it as part of an immunotherapy or desensitization program, stopping abruptly may cause your allergic symptoms to return or worsen. It is always best to consult your healthcare provider before discontinuing any biological extract. They may recommend a gradual decrease in dose to monitor how your immune system responds. If you experience any new or returning symptoms after stopping, report them to your doctor immediately.
If you miss a dose of Sus Scrofa Lung, take it as soon as you remember. If it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for the missed one, as this can increase the risk of gastrointestinal upset or an allergic reaction. Consistency is important for biological extracts, so try to use a pill organizer or phone alarm to help you remember. If you miss multiple doses, contact your doctor for advice on how to resume therapy.
There is no clinical evidence to suggest that Sus Scrofa Lung causes significant weight gain. The extract consists primarily of proteins, peptides, and vitamins, which have negligible caloric content at standard supplemental doses. If you experience rapid weight gain or swelling (edema) while taking this product, it may be a sign of an allergic reaction or an underlying kidney issue rather than true fat gain. In such cases, you should seek medical evaluation immediately. Always monitor your weight and report any sudden changes to your healthcare provider.
Sus Scrofa Lung can interact with several types of medications, including blood thinners like warfarin, immunosuppressants, and certain antacids. The Vitamin C component can also interfere with the accuracy of some lab tests, such as blood sugar and fecal occult blood tests. Because it is a complex biological product, it may have unpredictable interactions with other animal-derived drugs. It is crucial to provide your doctor with a complete list of all medications, herbs, and supplements you are currently taking. Your pharmacist can also help check for potential drug-drug interactions.
Because Sus Scrofa Lung is a complex biological extract rather than a simple chemical drug, it does not have a 'generic' version in the traditional sense. Instead, there are various 'branded' or 'non-standardized' versions produced by different manufacturers. These products can vary significantly in their protein concentration and purity. When switching between different brands of porcine lung extract, it is important to do so under medical supervision, as the potency may differ. Always check the label for the source and processing method (e.g., lyophilized) to ensure you are getting the product your doctor intended.